Nuvectis Pharma, Inc. (NVCT) Operating cash flow 2021–2025
Nuvectis Pharma, Inc. (NVCT) annual operating cash flow history from SEC filings — net cash provided by operating activities each fiscal year.
-$16.0MFY2025 · since FY2021: -$9.5M → -$16.0M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$16.0M | -30.7% |
| FY2024 | -$12.2M | +23.2% |
| FY2023 | -$16.0M | -17.7% |
| FY2022 | -$13.6M | -42.7% |
| FY2021 | -$9.5M | — |
Source: SEC XBRL filings · For reference only · Not investment advice